bezafibrate has been researched along with Lung Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ando, N; Chamoto, K; Fukushima, M; Hatae, R; Hirai, T; Hirano, T; Honjo, T; Ikematsu, Y; Kim, YH; Kojima, S; Matsuda, F; Nakanishi, Y; Nishio, K; Okamoto, I; Ozasa, H; Saeki, S; Sakagami, T; Sakai, K; Sakamori, Y; Sonomura, K; Taketsuna, M; Tanaka, K; Yoshida, H | 1 |
Chen, C; Dai, M; Li, H; Wang, D; Wang, W; Wu, L | 1 |
Capdevila, JH; Chen, X; Falck, JR; Gangadhariah, M; Hu, W; Jat, JL; Mont, S; Pozzi, A; Skrypnyk, N; Su, Y; Wei, S; Yang, S; Zent, R | 1 |
3 other study(ies) available for bezafibrate and Lung Neoplasms
Article | Year |
---|---|
Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancer.
Topics: Animals; B7-H1 Antigen; Bezafibrate; Carcinoma, Non-Small-Cell Lung; Ligands; Lung Neoplasms; Mice; Nivolumab; Peroxisome Proliferator-Activated Receptors; Programmed Cell Death 1 Receptor | 2022 |
PPARĪ± ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.
Topics: Animals; Antineoplastic Agents; Benzoates; Bezafibrate; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclooxygenase Inhibitors; Cytochrome P450 Family 2; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eicosanoids; Indomethacin; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Metastasis; Neovascularization, Pathologic; Oxazoles; PPAR alpha; Pyrimidines; Treatment Outcome; Xenograft Model Antitumor Assays | 2019 |
PPARĪ± activation can help prevent and treat non-small cell lung cancer.
Topics: Animals; Arachidonic Acids; Bezafibrate; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Disease Models, Animal; Endothelial Cells; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; PPAR alpha; Pyrimidines | 2014 |